TrialX
Image

The Study of Biological Prosthetic Heart Valves With the "Easy Change" System

The Study of Biological Prosthetic Heart Valves With the "Easy Change" System

Recruiting
60 years and older
All
Phase N/A

Overview

The study of new biological heart valves with the "easy change" system, including an assessment of the basic hemodynamic characteristics of the prosthesis, complications associated with valve implantation, and general mortality

Eligibility

Inclusion Criteria:

  1. aortic valve disease requiring surgical disease patients without symptoms with severe aortic stenosis - indexed area of the opening less than 0.5 cm2 / m2, average gradient more than 40 mm RT. Art;
    • patients who require coronary artery bypass grafting with moderate aortic stenosis - indexed area of the hole 0.5 - 1 cm2 / m2, the average gradient is more than 20 mm RT. Art., Regardless of symptoms;patients with symptoms of aortic stenosis, regardless of the severity of stenosis)
  2. mitral valve disease requiring surgical disease

Exclusion Criteria:

  1. the need for prosthetics of two or more valves
  2. patients with a decrease in LVEF of less than 45%;
  3. the presence of a competing disease or concomitant pathology that significantly affects the prognosis of quality of life or the likelihood of death
  4. high pulmonary hypertension (SDJ above 60 mm Hg. Art.);
  5. the diameter of the ascending aorta is more than 45 mm;
  6. unwillingness of the patient to participate in the study.

Study details
    Heart disease
    Heart disease
    VALVULAR HEART DISEASE

NCT04442100

Tomsk National Research Medical Center of the Russian Academy of Sciences

16 February 2024

Step 1 Get in touch with the nearest study center
Message sent successfully.
We have submitted the information you provided to the research team at the location you chose. For your records, we have sent a copy of the message to your email address.
If you would like to be informed of other studies that may be of interest to you, you may sign up for Patient Notification Service.
Sign up

Send a message

Enter your contact details to connect with study team


Email

View email

Phone

Phone country flag

View phone
Investigator Avatar

Primary Contact

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.